» Articles » PMID: 37362144

External Quality Control in Laboratory Medicine. Progresses and Future

Overview
Journal Adv Lab Med
Publisher De Gruyter
Specialty Biochemistry
Date 2023 Jun 26
PMID 37362144
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: An external quality control program distributes same control samples to various laboratories and evaluates results obtained with a common criterion. The aim of this work is to summarize the evolution of various types of external programs, to point out the progresses ant to preclude practical consequences of the participant laboratories.

Content: The material consists on a brief revision of the different types of external programs that have been used for the last forty years. The method is the critical analysis of the strong and weak points of each program model, from the light of our experience. External quality assessment (EQA) programs were initiated at half the XX century, evidencing big discrepancies among laboratory results. EQA were developed in various countries and some mechanisms to harmonize them were proposed: to establish common performance specifications derived from biological variation, to use EQS as educational tool. Since the 2000 important advances were seen: to focus EQA to assure the adequate clinical use of laboratory tests, to use commutable controls, to harmonize the different EQA models, to promote a forum for co-operation and exchange of knowledge on quality-related matters for EQA organizers.

Summary And Outlook: To participate in an EQA with commutable-reference method assigned values controls allows to know the real inaccuracy of results and their impact on patient' samples. To participate in a EQA with non commutable controls allows to know whether the individual laboratory performance agrees with that from other laboratories using same analytical method.

Citing Articles

Prediction interval: A powerful statistical tool for monitoring patients and analytical systems.

Coskun A Biochem Med (Zagreb). 2024; 34(2):020101.

PMID: 38665871 PMC: 11042565. DOI: 10.11613/BM.2024.020101.


Comparison of Sigma metrics computed by three bias estimation approaches for 33 chemistry and 26 immunoassay analytes.

Ercan S Adv Lab Med. 2024; 4(3):236-245.

PMID: 38162416 PMC: 10756147. DOI: 10.1515/almed-2022-0095.


.

Ercan S Adv Lab Med. 2024; 4(3):246-257.

PMID: 38162415 PMC: 10756148. DOI: 10.1515/almed-2023-0095.


Internal quality control and external quality assurance: a great past opens the way to a bright future.

Plebani M Adv Lab Med. 2023; 3(3):215-220.

PMID: 37362140 PMC: 10197377. DOI: 10.1515/almed-2022-0075.

References
1.
Badrick T, Stavelin A . Harmonising EQA schemes the next frontier: challenging the status quo. Clin Chem Lab Med. 2020; 58(11):1795-1797. DOI: 10.1515/cclm-2020-0343. View

2.
Llopis M, Bauca J, Barba N, Alvarez V, Ventura M, Ibarz M . Spanish Preanalytical Quality Monitoring Program (SEQC), an overview of 12 years' experience. Clin Chem Lab Med. 2016; 55(4):530-538. DOI: 10.1515/cclm-2016-0382. View

3.
Valenstein P . Laboratory turnaround time. Am J Clin Pathol. 1996; 105(6):676-88. DOI: 10.1093/ajcp/105.6.676. View

4.
Buttner J, Borth R, BOUTWELL J, Broughton P, Bowyer R . Approved recommendation (1983) on quality control in clinical chemistry. Part 3. External quality control. J Clin Chem Clin Biochem. 1983; 21(12):885-92. View

5.
Rioja R, Ventura M, Llopis M, Bauca J, Caballero Garralda A, Ibarz M . External quality assessment of serum indices: Spanish SEQC-ML program. Clin Chem Lab Med. 2021; 60(1):66-73. DOI: 10.1515/cclm-2021-0786. View